For the full year 2025, CFO Birkemeyer reported, "we now expect total revenue in the range of $310 million to $315 million, representing growth of approximately 6% to 8% year-over-year." The guidance ...

The average one-year price target for Tactile Systems Technology (NasdaqGM:TCMD) has been revised to $30.34 / share. This is an increase of 23.96% from the prior estimate of $24.48 dated December 18, ...

Tactile Systems (NASDAQ:TCMD) extended its post-market losses on Tuesday after the Minnesota-based MedTech fell short of Street forecasts for Q3 2024 revenue, prompting BTIG to downgrade its stock to ...

CEO Sheri Dodd highlighted that total revenue for Q1 2025 grew slightly by 0.3% year-over-year to $61.3 million. However, lymphedema revenue decreased by 3% to $50.6 million, while airway clearance ...

Tactile Medical will release Q1 fiscal 2025 financial results on May 5, 2025, with a conference call at 5 PM ET. Tactile Systems Technology, Inc. announced that it will release its first quarter ...

Tactile Medical reports Q1 2025 results with slight revenue growth, increased gross margin, and a higher net loss compared to Q1 2024. Tactile Systems Technology, Inc. reported its financial results ...

Tactile Systems Technology ( (TCMD)) has released its Q3 earnings. Here is a breakdown of the information Tactile Systems Technology presented to its investors. Tactile Systems Technology, Inc., known ...

Reports Q4 revenue $85.6M, consensus $85.39M. “Our fourth quarter results capped off a dynamic year for Tactile, during which we launched our next-generation lymphedema platform, generated clinical ...

Tactile Medical's fourth-quarter 2023 revenue grew 5% year over year to $77.7 million, translating to adjusted (non-GAAP) net income of $8.9 million, or $0.37 per share. Analysts, on average, were ...